Di Pardo, Alba
Ciaglia, Elena http://orcid.org/0000-0002-8035-4583
Cattaneo, Monica
Maciag, Anna
Montella, Francesco
Lopardo, Valentina
Ferrario, Anna
Villa, Francesco http://orcid.org/0000-0002-1696-6657
Madonna, Michele
Amico, Enrico
Carrizzo, Albino
Damato, Antonio
Pepe, Giuseppe
Marracino, Federico
Auricchio, Alberto http://orcid.org/0000-0002-0832-2472
Vecchione, Carmine
Maglione, Vittorio http://orcid.org/0000-0002-6906-7372
Puca, Annibale A. http://orcid.org/0000-0002-0347-1460
Funding for this research was provided by:
Fondazione Umberto Veronesi (2198 to EC)
Fondazione Cariplo (2016-0874)
Italian Ministry of Health (Ricerca Corrente) funding program
Article History
Received: 7 April 2020
Revised: 1 July 2020
Accepted: 3 July 2020
First Online: 18 July 2020
Conflict of interest
: A.A.P. and C.V. hold shares of LGV1 start-up, a spin-off of University of Salerno that own patents on LAV-BPIFB4 use in therapy.